Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway.

MLA

Il-Gyu Ko, et al. “Adenosine A2A Receptor Agonist Polydeoxyribonucleotide Ameliorates Short-Term Memory Impairment by Suppressing Cerebral Ischemia-Induced Inflammation via MAPK Pathway.” PLoS ONE, vol. 16, no. 3, Jan. 2021, p. e0248689. EBSCOhost, https://doi.org/10.1371/journal.pone.0248689.

APA

Il-Gyu Ko, Jun-Jang Jin, Lakkyong Hwang, Sang-Hoon Kim, Chang-Ju Kim, Jung Won Jeon, Jun-Young Chung, & Jin Hee Han. (2021). Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway. PLoS ONE, 16(3), e0248689. https://doi.org/10.1371/journal.pone.0248689

Chicago

Il-Gyu Ko, Jun-Jang Jin, Lakkyong Hwang, Sang-Hoon Kim, Chang-Ju Kim, Jung Won Jeon, Jun-Young Chung, and Jin Hee Han. 2021. “Adenosine A2A Receptor Agonist Polydeoxyribonucleotide Ameliorates Short-Term Memory Impairment by Suppressing Cerebral Ischemia-Induced Inflammation via MAPK Pathway.” PLoS ONE 16 (3): e0248689. doi:10.1371/journal.pone.0248689.